Literature DB >> 18193093

Many roads lead to oncogene-induced senescence.

S Courtois-Cox1, S L Jones, K Cichowski.   

Abstract

Oncogene-induced senescence is a mechanism of tumor suppression that restricts the progression of benign tumors. Important advances have been made toward elucidating the mechanisms that regulate this response; however, there is presently no unified model that integrates all current findings. DNA damage, replicative stress, reactive oxygen species, heterochromatin formation and negative feedback signaling networks have all been proposed to play an integral role in promoting senescence in response to various oncogenic insults. In all cases, these signals have been shown to function through Rb and p53, but utilize different intermediaries. Thus, it appears that senescence is not triggered by a single, linear series of events, but instead is regulated by a complex signaling network. Accordingly, multiple proteins may cooperate to establish a senescence response, but the limiting signal(s) may be dictated by the initiating genetic alteration and/or tissue type. This review will focus on integrating current models and will highlight data that provide new insight into the signals that function to suppress human tumor development.

Entities:  

Mesh:

Year:  2008        PMID: 18193093     DOI: 10.1038/sj.onc.1210950

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  177 in total

Review 1.  Apoptosis and aging: increased resistance to apoptosis enhances the aging process.

Authors:  Antero Salminen; Johanna Ojala; Kai Kaarniranta
Journal:  Cell Mol Life Sci       Date:  2010-11-30       Impact factor: 9.261

2.  p53-dependent induction of prostate cancer cell senescence by the PIM1 protein kinase.

Authors:  Marina Zemskova; Michael B Lilly; Ying-Wei Lin; Jin H Song; Andrew S Kraft
Journal:  Mol Cancer Res       Date:  2010-07-20       Impact factor: 5.852

Review 3.  Cellular Senescence: The Trojan Horse in Chronic Lung Diseases.

Authors:  Shruthi Hamsanathan; Jonathan K Alder; Jacobo Sellares; Mauricio Rojas; Aditi U Gurkar; Ana L Mora
Journal:  Am J Respir Cell Mol Biol       Date:  2019-07       Impact factor: 6.914

Review 4.  Mitochondrial dynamics as regulators of cancer biology.

Authors:  Andrew Paul Trotta; Jerry Edward Chipuk
Journal:  Cell Mol Life Sci       Date:  2017-01-12       Impact factor: 9.261

5.  SIRT1 is required for oncogenic transformation of neural stem cells and for the survival of "cancer cells with neural stemness" in a p53-dependent manner.

Authors:  Ji-Seon Lee; Jeong-Rak Park; Ok-Seon Kwon; Tae-Hee Lee; Ichiro Nakano; Hiroyuki Miyoshi; Kwang-Hoon Chun; Myung-Jin Park; Hong Jun Lee; Seung U Kim; Hyuk-Jin Cha
Journal:  Neuro Oncol       Date:  2014-08-05       Impact factor: 12.300

Review 6.  Emerging roles of the p38 MAPK and PI3K/AKT/mTOR pathways in oncogene-induced senescence.

Authors:  Yingxi Xu; Na Li; Rong Xiang; Peiqing Sun
Journal:  Trends Biochem Sci       Date:  2014-05-09       Impact factor: 13.807

Review 7.  The Chromatin Landscape of Cellular Senescence.

Authors:  Steven W Criscione; Yee Voan Teo; Nicola Neretti
Journal:  Trends Genet       Date:  2016-09-28       Impact factor: 11.639

8.  Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.

Authors:  J Bargiela-Iparraguirre; L Prado-Marchal; N Pajuelo-Lozano; B Jiménez; R Perona; I Sánchez-Pérez
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 9.  Inflammatory signaling and cellular senescence.

Authors:  Jian-Lin Ren; Jin-Shui Pan; Ya-Pi Lu; Peiqing Sun; Jiahuai Han
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

Review 10.  Cellular senescence and the senescent secretory phenotype: therapeutic opportunities.

Authors:  Tamara Tchkonia; Yi Zhu; Jan van Deursen; Judith Campisi; James L Kirkland
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.